Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionretinoic acid-responsive element binding

RARA RXRG

1.33e-047512GO:0044323
GeneOntologyMolecularFunctionnuclear receptor activity

RARA RARB RXRG

4.85e-0460513GO:0004879
GeneOntologyMolecularFunctionligand-activated transcription factor activity

RARA RARB RXRG

5.09e-0461513GO:0098531
GeneOntologyBiologicalProcessSertoli cell differentiation

RARA ATRX FSHR FNDC3A

1.29e-0633514GO:0060008
GeneOntologyBiologicalProcessSertoli cell development

ATRX FSHR FNDC3A

2.78e-0524513GO:0060009
GeneOntologyBiologicalProcessepithelial cell development

RARA RARB ATRX FSHR PKHD1 FNDC3A

5.12e-05269516GO:0002064
GeneOntologyBiologicalProcessretinoic acid receptor signaling pathway

RARA RARB RXRG

1.13e-0438513GO:0048384
GeneOntologyBiologicalProcessembryonic camera-type eye development

IFT140 ZEB1 RARA

1.88e-0445513GO:0031076
GeneOntologyBiologicalProcesslimb development

TBC1D32 IFT140 RARA RARB ATRX

2.26e-04224515GO:0060173
GeneOntologyBiologicalProcessappendage development

TBC1D32 IFT140 RARA RARB ATRX

2.26e-04224515GO:0048736
DomainRetinoic_acid_rcpt

RARA RARB

4.03e-054492IPR003078
Domainzf-C4

RARA RARB RXRG

2.38e-0446493PF00105
DomainZnf_hrmn_rcpt

RARA RARB RXRG

2.38e-0446493IPR001628
DomainNuclear_hrmn_rcpt

RARA RARB RXRG

2.38e-0446493IPR001723
DomainNUCLEAR_REC_DBD_2

RARA RARB RXRG

2.38e-0446493PS51030
DomainNUCLEAR_REC_DBD_1

RARA RARB RXRG

2.38e-0446493PS00031
DomainZnF_C4

RARA RARB RXRG

2.38e-0446493SM00399
Domain-

RARA RARB RXRG

2.54e-04474931.10.565.10
DomainHOLI

RARA RARB RXRG

2.70e-0448493SM00430
DomainNucl_hrmn_rcpt_lig-bd

RARA RARB RXRG

2.70e-0448493IPR000536
DomainHormone_recep

RARA RARB RXRG

2.70e-0448493PF00104
Domain-

RARA RARB RXRG

4.49e-04574933.30.50.10
DomainZnf_NHR/GATA

RARA RARB RXRG

4.73e-0458493IPR013088
Domain-

ZEB1 ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

1.85e-036794973.30.160.60
DomainZnf_C2H2/integrase_DNA-bd

ZEB1 ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

2.10e-03694497IPR013087
DomainTIG

PKHD1 CAMTA2

2.99e-0331492PF01833
DomainIPT

PKHD1 CAMTA2

3.18e-0332492IPR002909
DomainTPR-like_helical_dom

IFT140 TRAPPC8 IFIT2 IFIT3

3.22e-03233494IPR011990
DomainZINC_FINGER_C2H2_2

ZEB1 ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

3.88e-03775497PS50157
DomainZINC_FINGER_C2H2_1

ZEB1 ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

3.93e-03777497PS00028
DomainZnf_C2H2-like

ZEB1 ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

4.49e-03796497IPR015880
DomainZnf_C2H2

ZEB1 ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

4.77e-03805497IPR007087
DomainZnF_C2H2

ZEB1 ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

4.87e-03808497SM00355
DomainTPR-contain_dom

IFT140 IFIT2 IFIT3

7.14e-03150493IPR013026
DomainTPR_2

IFIT2 IFIT3

7.62e-0350492PF07719
DomainTPR_2

IFIT2 IFIT3

7.62e-0350492IPR013105
DomainTPR_8

IFIT2 IFIT3

8.53e-0353492PF13181
Domainzf-C2H2

ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

9.19e-03693496PF00096
DomainTPR_REGION

IFT140 IFIT2 IFIT3

9.26e-03165493PS50293
DomainTPR

IFT140 IFIT2 IFIT3

9.26e-03165493PS50005
PathwayWP_VITAMIN_A1_AND_A5X_PATHWAYS

RARA RARB RXRG

2.79e-076353M48097
PathwayPID_RXR_VDR_PATHWAY

RARA RARB RXRG

3.51e-0526353M162
PathwayREACTOME_INTERFERON_ALPHA_BETA_SIGNALING

UBA52 OAS2 IFIT2 IFIT3

3.99e-0578354M973
PathwayPID_RETINOIC_ACID_PATHWAY

RARA RARB RXRG

5.44e-0530353M207
PathwayWP_NUCLEAR_RECEPTORS

RARA RARB RXRG

1.11e-0438353M39657
PathwayWP_NUCLEAR_RECEPTORS

RARA RARB RXRG

1.11e-0438353MM15865
PathwayWP_VITAMIN_A_AND_CAROTENOID_METABOLISM

RARA RARB RXRG

1.62e-0443353M39554
PathwayREACTOME_SIGNALING_BY_RETINOIC_ACID

RARA RARB RXRG

1.62e-0443353M27443
PathwayWP_RETINOL_METABOLISM

RARA RARB RXRG

1.73e-0444353MM15851
PathwayREACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY

RARA RARB RXRG

2.25e-0448353MM14987
PathwayREACTOME_SIGNALING_BY_RETINOIC_ACID

RARA RARB RXRG

2.39e-0449353MM15186
PathwayREACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY

RARA RARB RXRG

3.02e-0453353M8276
PathwayREACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION

UBA52 IKBKE

3.25e-0411352M48241
PathwayWP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM

CELSR1 RARA RARB

4.35e-0460353M40048
PathwayREACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7

UBA52 IKBKE

4.59e-0413352M27884
PathwayREACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7

UBA52 IKBKE

5.35e-0414352M48239
PathwayREACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING

UBA52 IKBKE

5.35e-0414352MM15642
PathwayREACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7

UBA52 IKBKE

6.16e-0415352MM17228
PathwayREACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE

UBA52 IKBKE

8.94e-0418352M970
PathwayREACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE

UBA52 IKBKE

9.97e-0419352MM15644
Pubmed

mRNA expression pattern of retinoic acid and retinoid X nuclear receptor subtypes in human thyroid papillary carcinoma.

RARA RARB RXRG

2.97e-09351323969901
Pubmed

Retinoic acid signaling is necessary for the development of the organ of Corti.

RARA RARB RXRG

2.96e-08551310452855
Pubmed

Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes.

RARA RARB RXRG

5.92e-08651311328745
Pubmed

The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.

RARA RARB RXRG

5.92e-0865139153406
Pubmed

Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear.

RARA RARB RXRG

5.92e-0865139548551
Pubmed

Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis.

RARA RARB RXRG

5.92e-0865139464546
Pubmed

Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid.

RARA RARB RXRG

5.92e-08651320557428
Pubmed

RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells.

RARA RARB RXRG

5.92e-0865138801169
Pubmed

A decade of molecular biology of retinoic acid receptors.

RARA RARB RXRG

5.92e-0865138801176
Pubmed

The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development.

RARA RARB RXRG

5.92e-0865139806918
Pubmed

A genetic dissection of the retinoid signalling pathway in the mouse.

RARA RARB RXRG

5.92e-08651310604193
Pubmed

Retinoid signaling and the generation of regional and cellular diversity in the embryonic mouse spinal cord.

RARA RARB RXRG

5.92e-0865138563020
Pubmed

Mesenchymal/epithelial regulation of retinoic acid signaling in the olfactory placode.

RARA RARB RXRG

5.92e-08651312941622
Pubmed

Effect of retinoid status on the messenger ribonucleic acid expression of nuclear retinoid receptors alpha, beta, and gamma, and retinoid X receptors alpha, beta, and gamma in the mouse testis.

RARA RARB RXRG

5.92e-0865139075714
Pubmed

Vitamin A deficiency and mutations of RXRalpha, RXRbeta and RARalpha lead to early differentiation of embryonic ventricular cardiomyocytes.

RARA RARB RXRG

1.04e-0775139428411
Pubmed

Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha.

RARA RARB RXRG

1.04e-07751311493527
Pubmed

Retinoid signaling controls mouse pancreatic exocrine lineage selection through epithelial-mesenchymal interactions.

RARA RARB RXRG

1.04e-07751312360493
Pubmed

Comparison of the expression patterns of newly identified zebrafish retinoic acid and retinoid X receptors.

RARA RARB RXRG

1.04e-07751317195188
Pubmed

Age-dependent retinoic acid regulation of gene expression distinguishes the cervical, thoracic, lumbar, and sacral spinal cord regions during development.

RARA RARB RXRG

1.04e-07751310449983
Pubmed

Structural variants in the retinoid receptor genes in patients with schizophrenia and other psychiatric diseases.

RARA RARB RXRG

1.04e-07751315635645
Pubmed

Creatine kinase (CK) in skeletal muscle energy metabolism: a study of mouse mutants with graded reduction in muscle CK expression.

RARA RARB RXRG

1.04e-0775138090775
Pubmed

Dorsal and ventral rentinoic territories defined by retinoic acid synthesis, break-down and nuclear receptor expression.

RARA RARB RXRG

1.65e-07851310490294
Pubmed

Expression of nuclear retinoic acid receptors during mouse odontogenesis.

RARA RARB RXRG

1.65e-0785137988794
Pubmed

Retinoids and adipose tissues: metabolism, cell differentiation and gene expression.

RARA RARB RXRG

1.65e-07851310094571
Pubmed

Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells.

RARA RARB RXRG

1.65e-07851317124491
Pubmed

A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells.

RARA RARB RXRG

2.48e-0795137823919
Pubmed

Retinoic acid signaling maintains epithelial and mesenchymal progenitors in the developing mouse ureter.

RARA RARB RXRG

4.86e-071151329093497
Pubmed

Differential expression of transcripts encoding retinoid binding proteins and retinoic acid receptors during placentation of the mouse.

RARA RARB RXRG

6.47e-07125139022057
Pubmed

Retinoic Acid Receptors Control Spermatogonia Cell-Fate and Induce Expression of the SALL4A Transcription Factor.

RARA RARB RXRG

6.47e-071251326427057
Pubmed

Absence of TGFbeta signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm.

RARA RARB ACVR1

8.41e-071351319165826
Pubmed

Retinoic acid regulates murine enteric nervous system precursor proliferation, enhances neuronal precursor differentiation, and reduces neurite growth in vitro.

RARA RARB RXRG

1.07e-061451318561907
Pubmed

Retinoic acid induces prostatic bud formation.

RARA RARB RXRG

1.07e-061451318393306
Pubmed

LIM kinase 1 - dependent cofilin 1 pathway and actin dynamics mediate nuclear retinoid receptor function in T lymphocytes.

RARA RARB RXRG

1.07e-061451321923909
Pubmed

Understanding abnormal retinoid signaling as a causative mechanism in congenital diaphragmatic hernia.

RARA RARB RXRG

1.33e-061551319448158
Pubmed

Expression of aldehyde dehydrogenase family 1, member A3 in glycogen trophoblast cells of the murine placenta.

RARA RARB RXRG

1.64e-061651325577283
Pubmed

External genitalia formation: role of fibroblast growth factor, retinoic acid signaling, and distal urethral epithelium.

RARA RARB RXRG

1.64e-061651311795391
Pubmed

Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation.

RARA RARB

2.11e-06251229921692
Pubmed

Retinoic acid receptors in normal growth and development.

RARA RARB

2.11e-0625121330302
Pubmed

Compartment-selective sensitivity of cardiovascular morphogenesis to combinations of retinoic acid receptor gene mutations.

RARA RARB

2.11e-0625129168777
Pubmed

Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause.

FSHR MAP3K5

2.11e-06251218676690
Pubmed

Retinoid hyposignaling contributes to aging-related decline in hippocampal function in short-term/working memory organization and long-term declarative memory encoding in mice.

RARB RXRG

2.11e-06251218171945
Pubmed

Embryonic development and pattern formation.

RARA RXRG

2.11e-0625128801178
Pubmed

Retinoic acid regulates gene expression of retinoic acid receptors alpha, beta and gamma in F9 mouse teratocarcinoma cells.

RARA RARB

2.11e-0625121334013
Pubmed

Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in culture.

RARA RXRG

2.11e-06251219106195
Pubmed

Biological functional annotation of retinoic acid alpha and beta in mouse liver based on genome-wide binding.

RARA RARB

2.11e-06251224833708
Pubmed

Purification and crystallization of the heterodimeric complex of RARbeta and RXRalpha ligand-binding domains in the active conformation.

RARA RARB

2.11e-06251215159591
Pubmed

[The significance of expression of isoforms RARa1 and RARa2 in response to medicinal therapy and in evaluation of total survival of patients with primarily detected multiple myeloma].

RARA RARB

2.11e-06251230601638
Pubmed

Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types.

RARA RARB

2.11e-0625127644503
Pubmed

Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer.

RARA RARB

2.11e-06251227306217
Pubmed

Anticancer effect of retinoic acid via AP-1 activity repression is mediated by retinoic acid receptor alpha and beta in gastric cancer cells.

RARA RARB

2.11e-06251212009305
Pubmed

Ebf1 controls early cell differentiation in the embryonic striatum.

RARA RARB RXRG

2.39e-061851310556054
Pubmed

Removal of maternal retinoic acid by embryonic CYP26 is required for correct Nodal expression during early embryonic patterning.

RARA RARB RXRG

3.33e-062051319605690
Pubmed

Identification of endogenous retinoids, enzymes, binding proteins, and receptors during early postimplantation development in mouse: important role of retinal dehydrogenase type 2 in synthesis of all-trans-retinoic acid.

RARA RARB RXRG

4.49e-062251310753524
Pubmed

Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells.

RARA RARB RXRG

5.15e-062351319737349
Pubmed

Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants.

RARA RARB

6.32e-0635127607068
Pubmed

Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants.

RARA RARB

6.32e-0635127607067
Pubmed

Impaired distribution of retinoic acid receptors in the hindgut-tailgut region of murine embryos with anorectal malformations.

RARA RARB

6.32e-06351211172439
Pubmed

Cloning of several genes coding for retinoic acid nuclear receptors in the mouse embryonal carcinoma cell line PCC7-MZ1.

RARA RARB

6.32e-0635128383767
Pubmed

Retinoic acid receptor gamma: specific immunodetection and phosphorylation.

RARA RARB

6.32e-0635121655807
Pubmed

A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia.

RARA RARB

6.32e-06351217252005
Pubmed

Retinoic acid down-regulation of fibronectin and retinoic acid receptor alpha proteins in NIH-3T3 cells. Blocks of this response by ras transformation.

RARA RARB

6.32e-0635128626453
Pubmed

Function of retinoic acid receptor gamma in the mouse.

RARA RARB

6.32e-0635128388780
Pubmed

Contribution of retinoic acid receptor beta isoforms to the formation of the conotruncal septum of the embryonic heart.

RARA RARB

6.32e-0635129659935
Pubmed

Retinoids and vertebrate development.

RARA RARB

6.32e-0635127910825
Pubmed

Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo.

RARA RARB

6.32e-06351210842077
Pubmed

Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity.

RARA RARB

6.32e-06351211245412
Pubmed

Altered expression of retinoic acid (RA) receptor mRNAs in the fetal mouse secondary palate by all-trans and 13-cis RAs: implications for RA-induced teratogenesis.

RARA RARB

6.32e-06351210100049
Pubmed

Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.

IKBKE IFIT2

6.32e-06351222065572
Pubmed

IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA.

IFIT2 IFIT3

6.32e-06351229554348
Pubmed

Both retinoic acid receptors alpha (RARalpha) and gamma (RARgamma) are able to initiate mouse upper-lip skin glandular metaplasia.

RARA RARB

6.32e-0635129699718
Pubmed

Mammalian hexokinase 1: evolutionary conservation and structure to function analysis.

RARA RARB

6.32e-0635121783373
Pubmed

Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues.

RARA RARB

6.32e-0635121283441
Pubmed

The interferon stimulated gene 54 promotes apoptosis.

IFIT2 IFIT3

6.32e-06351221190939
Pubmed

DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.

RARB CCND2

6.32e-06351219945765
Pubmed

Synergistic activation of RARβ and RARγ nuclear receptors restores cell specialization during stem cell differentiation by hijacking RARα-controlled programs.

RARA RARB

6.32e-06351236446525
Pubmed

Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.

RARA RARB

6.32e-06351215528208
Pubmed

Impaired locomotion and dopamine signaling in retinoid receptor mutant mice.

RARB RXRG

6.32e-0635129452386
Pubmed

Association of retinoic acid receptor genes with meningomyelocele.

RARA RARB

6.32e-06351221254357
Pubmed

Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes.

RARA RARB

6.32e-0635121655630
Pubmed

Arg278, but not Lys229 or Lys236, plays an important role in the binding of retinoic acid by retinoic acid receptor gamma.

RARA RARB

6.32e-0635129852056
Pubmed

Differential expression of retinoic acid receptors in normal and malignant esophageal tissues.

RARA RARB

6.32e-06351215255287
Pubmed

Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia.

RARA RARB

6.32e-06351217244680
Pubmed

The molecular and genetic dissection of the retinoid signalling pathway.

RARA RARB

6.32e-0635128276261
Pubmed

Interferon-stimulated gene (ISG) 60, as well as ISG56 and ISG54, positively regulates TLR3/IFN-β/STAT1 axis in U373MG human astrocytoma cells.

IFIT2 IFIT3

6.32e-06351226423178
Pubmed

Requirement of retinoic acid receptor isotypes alpha, beta, and gamma during the initial steps of neural differentiation of PCC7 cells.

RARA RARB

6.32e-06351215831518
Pubmed

Working memory deficits in retinoid X receptor gamma-deficient mice.

RARB RXRG

6.32e-06351215897255
Pubmed

Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus.

RARA RARB

6.32e-0635128136307
Pubmed

Molecular cloning and characterization of a murine LPS-inducible cDNA.

IFIT2 IFIT3

6.32e-0635128207206
Pubmed

Genes involved in cell adhesion and signaling: a new repertoire of retinoic acid receptor target genes in mouse embryonic fibroblasts.

RARA RARB

6.32e-06351224357724
Pubmed

Retinoic acid and mouse skin morphogenesis. I. Expression pattern of retinoic acid receptor genes during hair vibrissa follicle, plantar, and nasal gland development.

RARA RARB

6.32e-0635128027572
Pubmed

Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3.

IFIT2 IFIT3

6.32e-06351225252956
Pubmed

Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin.

RARA RARB

6.32e-0635122544807
Pubmed

[Genetic expression and morphogenesis of the skin in vertebrates].

RARA RARB

6.32e-0635128099268
Pubmed

Regulation of retinoic acid receptor alpha by protein kinase C in B16 mouse melanoma cells.

RARA RARB

6.32e-06351212000751
Pubmed

Specificity of retinoid receptor gene expression in mouse cervical epithelia.

RARA RARB

6.32e-0635128156902
Pubmed

Characterization of retinoic acid receptor-deficient keratinocytes.

RARA RARB

6.32e-06351210748128
Pubmed

An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression.

RARB RXRG

6.32e-0635129883728
Pubmed

Strain difference and mode of inheritance of the susceptibility to passive cutaneous anaphylaxis mediated by allogeneic IgE antibody in the mouse.

RARA RARB

6.32e-0635122737701
Pubmed

Immunohistochemical localization of the retinoic Acid receptors in human prostate.

RARA RARB

6.32e-06351212399530
Pubmed

Combinatorial knockout of RARα, RARβ, and RARγ completely abrogates transcriptional responses to retinoic acid in murine embryonic stem cells.

RARA RARB

6.32e-06351229848550
GeneFamilyNuclear hormone receptors

RARA RARB RXRG

1.60e-044939371
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZEB1 ZNF257 ZNF521 ZNF407 ZNF721 ZNF260 ZNF292

7.67e-0471839728
CoexpressionGSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN

SAMD9L ZEB1 TESMIN GVINP1 SIPA1L1 OAS2 IFIT2 IFIT3

8.24e-10160518M8664
CoexpressionMOSERLE_IFNA_RESPONSE

SAMD9L OAS2 IFIT2 IFIT3

3.85e-0731514M3218
CoexpressionSCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP

SAMD9L ATG3 NEK7 MCM2 OAS2 IFIT2 IFIT3 MAP3K5

4.10e-07356518M41052
CoexpressionQUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP

SAMD9L OAS2 IFIT2 IFIT3

1.95e-0646514M41048
CoexpressionQUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP

SAMD9L OAS2 IFIT2 IFIT3

1.95e-0646514M41047
CoexpressionTAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP

SAMD9L ZEB1 ZNF521 OAS2 IFIT2 IFIT3

2.02e-06193516M13479
CoexpressionGSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP

SAMD9L ATG3 PKHD1 OAS2 IFIT2 IFIT3

2.41e-06199516M9306
CoexpressionGSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP

SAMD9L ADAM19 OAS2 CAMTA2 IFIT2 IFIT3

2.48e-06200516M8073
CoexpressionHE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL

SAMD9L IKBKE OAS2 IFIT2 IFIT3

4.66e-06126515M45721
CoexpressionBOWIE_RESPONSE_TO_TAMOXIFEN

OAS2 IFIT2 IFIT3

5.55e-0618513M3283
CoexpressionYOSHIMURA_MAPK8_TARGETS_DN

IVD ATP6V1B2 ZEB1 SIPA1L1 PITPNA ACVR1 ZNF292

8.37e-06379517M1885
CoexpressionERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP

SAMD9L OAS2 IFIT2 IFIT3

1.19e-0572514M41023
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

UBA52 SAMD9L ZEB1 ADAM19 GVINP1 ATRX NEK7 OAS2 ZNF721 TRAPPC8 ZNF292 CCND2

2.21e-0514925112M40023
CoexpressionGSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN

ATP6V1B2 SAMD9L GVINP1 IFIT2 IFIT3

2.42e-05177515M7632
CoexpressionHECKER_IFNB1_TARGETS

SAMD9L OAS2 IFIT2 IFIT3

3.55e-0595514M3010
CoexpressionSOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN

OAS2 IFIT2 IFIT3

3.63e-0533513M41194
CoexpressionGSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN

SAMD9L PKHD1 OAS2 IFIT2 IFIT3

3.76e-05194515M4227
CoexpressionGSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN

SAMD9L IKBKE OAS2 IFIT2 IFIT3

3.85e-05195515M4292
CoexpressionGSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN

SAMD9L IKBKE OAS2 IFIT2 IFIT3

3.95e-05196515M4267
CoexpressionERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP

SAMD9L OAS2 IFIT2

3.98e-0534513M41094
CoexpressionGSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN

SAMD9L ADAM19 OAS2 IFIT2 IFIT3

4.04e-05197515M3344
CoexpressionGSE2706_UNSTIM_VS_8H_R848_DC_DN

SAMD9L SIPA1L1 OAS2 IFIT2 IFIT3

4.04e-05197515M4694
CoexpressionGSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP

SAMD9L TESMIN OAS2 IFIT2 IFIT3

4.04e-05197515M9797
CoexpressionGSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN

UBA52 OAS2 IFIT2 IFIT3 CCND2

4.24e-05199515M4635
CoexpressionGSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN

ATP6V1B2 GVINP1 OAS2 IFIT2 IFIT3

4.24e-05199515M8971
CoexpressionGSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP

ATRX CAMTA2 ACVR1 IFIT3 ZNF292

4.24e-05199515M8381
CoexpressionGSE30083_SP1_VS_SP4_THYMOCYTE_DN

SAMD9L ADAM19 IKBKE OAS2 MAP3K5

4.35e-05200515M5030
CoexpressionGSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN

ATG3 OAS2 FNDC3A IFIT2 IFIT3

4.35e-05200515M7595
CoexpressionGSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP

CELSR1 OAS2 USP9Y IFIT2 IFIT3

4.35e-05200515M7649
CoexpressionGSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN

CELSR1 ZEB1 IKBKE IFIT2 IFIT3

4.35e-05200515M9055
CoexpressionGSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP

SAMD9L OAS2 IFIT2 IFIT3 CCND2

4.35e-05200515M8554
CoexpressionHAN_JNK_SINGALING_UP

ZEB1 IFIT3 CCND2

4.35e-0535513M1596
CoexpressionERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP

SAMD9L OAS2 IFIT2

6.04e-0539513M41095
CoexpressionHAN_JNK_SINGALING_UP

ZEB1 IFIT3 CCND2

6.52e-0540513MM1183
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_UP

SAMD9L ZEB1 ATRX FNDC3A TRAPPC8 IFIT2 CCND2

6.55e-05523517M12707
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_UP

SAMD9L ZEB1 ATRX FNDC3A TRAPPC8 IFIT2 CCND2

7.46e-05534517MM1054
CoexpressionERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP

SAMD9L OAS2 IFIT2 IFIT3

8.56e-05119514M41139
CoexpressionHOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP

SAMD9L OAS2 IFIT2 IFIT3

8.56e-05119514M41109
CoexpressionHOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP

SAMD9L GVINP1 OAS2 IFIT2 IFIT3

8.60e-05231515M40995
CoexpressionDESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS

RARB SLCO6A1 RXRG

1.13e-0448513M40173
CoexpressionZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP

SAMD9L OAS2 IFIT2 IFIT3

1.24e-04131514M40875
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_IN_TADS

ATP6V1B2 ADAM19 ZDHHC6 SIPA1L1 C3orf70 MCM2 ACVR1 RXRG CCND2

1.27e-041009519M157
CoexpressionCAO_BLOOD_FLUMIST_AGE_05_14YO_CORRELATED_WITH_H3N2_VN_TITER_7DY_POSITIVE

OAS2 IFIT3

1.32e-049512M41098
CoexpressionCHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN

IFT140 SIPA1L1 PITPNA PKHD1 FNDC3A CCND2

1.35e-04407516M2214
CoexpressionSCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP

OAS2 IFIT2 IFIT3

1.70e-0455513M40901
CoexpressionSCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP

OAS2 IFIT2 IFIT3

1.70e-0455513M40900
CoexpressionLEE_TARGETS_OF_PTCH1_AND_SUFU_UP

ZEB1 MCM2 CCND2

1.79e-0456513M7669
CoexpressionSHEN_SMARCA2_TARGETS_UP

ATRX ATG3 ZDHHC6 NEK7 ACVR1 USP9Y

1.79e-04429516M29
CoexpressionLIANG_SILENCED_BY_METHYLATION_2

OAS2 IFIT2 IFIT3

1.99e-0458513M18085
CoexpressionGSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN

SURF2 PKHD1 IFIT3 CCND2

2.14e-04151514M369
CoexpressionLEE_TARGETS_OF_PTCH1_AND_SUFU_UP

ZEB1 MCM2 CCND2

2.20e-0460513MM601
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

ZEB1 ATRX SIPA1L1 NEK7 FNDC3A ACVR1 TRAPPC8 ZNF292

2.30e-04856518M4500
CoexpressionHOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP

SAMD9L ADAM19 IFIT2 IFIT3

2.61e-04159514M40998
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

ATRX NEK7 FNDC3A ACVR1 TRAPPC8 ZNF292

2.80e-04466516M13522
CoexpressionMATZUK_EARLY_ANTRAL_FOLLICLE

FSHR CCND2

2.86e-0413512M1822
CoexpressionGRANDVAUX_IRF3_TARGETS_UP

OAS2 IFIT3

2.86e-0413512M5133
CoexpressionBROWNE_INTERFERON_RESPONSIVE_GENES

OAS2 IFIT2 IFIT3

3.04e-0467513M9221
CoexpressionHE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL

SAMD9L IKBKE OAS2 IFIT2 IFIT3 ZNF260

3.13e-04476516M45717
CoexpressionGSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN

CHODL SIPA1L1 ACVR1 IFIT3

3.29e-04169514M8661
CoexpressionGSE37301_PRO_BCELL_VS_CD4_TCELL_UP

IVD GVINP1 IKBKE IFIT2

3.37e-04170514M8893
CoexpressionDOUGLAS_BMI1_TARGETS_DN

IVD RARB EXD2 IFIT2 IFIT3

3.58e-04314515M14279
CoexpressionBLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP

SAMD9L OAS2 IFIT2 IFIT3

3.68e-04174514M34028
CoexpressionTAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP

ADAM19 OAS2 IFIT2 IFIT3

3.84e-04176514M15588
CoexpressionGSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN

SAMD9L ZEB1 OAS2 IFIT3

3.92e-04177514M8666
CoexpressionSEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP

OAS2 IFIT2 IFIT3

4.25e-0475513M7284
CoexpressionBONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING

ZEB1 RARB IKBKE FNDC3A COLGALT1 MAP3K5

4.33e-04506516M253
CoexpressionGSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN

ATP6V1B2 SAMD9L IFIT2 IFIT3

4.45e-04183514M7627
CoexpressionTAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP

SAMD9L OAS2 IFIT2 IFIT3

4.45e-04183514M6670
CoexpressionBOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE

SAMD9L OAS2 IFIT3

4.76e-0478513M2532
CoexpressionTRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL

ATP6V1B2 ADAM19 RARA SIPA1L1 PITPNA FNDC3A IFIT3

4.80e-04724517M41700
CoexpressionBOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX

IFIT2 IFIT3

4.95e-0417512M6162
CoexpressionGSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN

SAMD9L OAS2 IFIT2 IFIT3

5.02e-04189514M4261
CoexpressionXIE_ST_HSC_S1PR3_OE_UP

SAMD9L OAS2 IFIT2 IFIT3

5.02e-04189514M41755
CoexpressionBLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP

SAMD9L DNAH17 OAS2 IFIT2 IFIT3

5.07e-04339515M34012
CoexpressionGSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP

SAMD9L OAS2 IFIT2 IFIT3

5.22e-04191514M7130
CoexpressionERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP

SAMD9L IFIT2

5.57e-0418512M40980
CoexpressionFAN_EMBRYONIC_CTX_NSC_1

ZEB1 CCND2

5.57e-0418512M39035
CoexpressionGSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP

SAMD9L GVINP1 IFIT2 IFIT3

5.76e-04196514M5337
CoexpressionGAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP

SAMD9L OAS2 IFIT2 IFIT3

5.76e-04196514M41141
CoexpressionGSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP

SAMD9L OAS2 COLGALT1 IFIT3

5.87e-04197514M3307
CoexpressionGSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN

SAMD9L OAS2 IFIT2 IFIT3

5.87e-04197514M4294
CoexpressionGSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP

SAMD9L OAS2 IFIT2 IFIT3

5.87e-04197514M7543
CoexpressionGSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN

IKBKE SIPA1L1 NEK7 ACVR1

5.87e-04197514M8755
CoexpressionCHEN_METABOLIC_SYNDROM_NETWORK

ATP6V1B2 ADAM19 IKBKE ZDHHC6 FSHR ZNF521 COLGALT1 IFIT2 IFIT3

5.89e-041242519M1920
CoexpressionGSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN

SAMD9L OAS2 IFIT2 IFIT3

5.98e-04198514M3302
CoexpressionGSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN

SAMD9L OAS2 IFIT2 IFIT3

5.98e-04198514M3296
CoexpressionGSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN

SAMD9L OAS2 IFIT2 IFIT3

5.98e-04198514M4264
CoexpressionGSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP

SAMD9L PITPNA ENPEP IFIT3

5.98e-04198514M7128
CoexpressionGSE22886_NAIVE_BCELL_VS_DC_UP

ZEB1 GVINP1 MCM2 USP9Y

5.98e-04198514M4483
CoexpressionGSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP

SURF2 DNAH17 IFIT3 ZMYM6

5.98e-04198514M4309
CoexpressionGSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN

SAMD9L OAS2 IFIT2 IFIT3

6.09e-04199514M3311
CoexpressionGSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP

RARB IFIT2 IFIT3 CCND2

6.09e-04199514M6260
CoexpressionGSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN

SAMD9L OAS2 IFIT2 IFIT3

6.09e-04199514M3286
CoexpressionGSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP

PITPNA OAS2 IFIT2 IFIT3

6.09e-04199514M7652
CoexpressionGSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP

ATP6V1B2 ZEB1 NEK7 IFIT2

6.09e-04199514M326
CoexpressionGSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN

ADAM19 IKBKE OAS2 IFIT2

6.09e-04199514M5206
CoexpressionGSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP

SAMD9L ADAM19 EXD2 TRAPPC8

6.09e-04199514M7553
CoexpressionGSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN

EXD2 DNAH17 NEK7 TRAPPC8

6.21e-04200514M9459
CoexpressionGSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP

CELSR1 SAMD9L ADAM19 VPS53

6.21e-04200514M4663
CoexpressionGSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN

SAMD9L OAS2 IFIT2 IFIT3

6.21e-04200514M3288
CoexpressionAtlasalpha beta T cells, T.8SP24-.Th, 4- 8+ TCRhi 24-/lo, Thymus, avg-3

CELSR1 ADAM19 IKBKE MCM2 OAS2 IFIT3 CCND2

1.97e-05351517GSM399379_500
CoexpressionAtlaskidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_100

SAMD9L GVINP1 ENPEP IFIT3

4.94e-0584514gudmap_kidney_adult_RenMedVasc_Tie2_100
CoexpressionAtlaskidney_adult_RenalCortexMixed_Std_k-means-cluster#1_top-relative-expression-ranked_200

SAMD9L IFIT3

5.63e-055512gudmap_kidney_adult_RenalCortexMixed_Std_k1_200
CoexpressionAtlaskidney_adult_RenMedVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_100

SAMD9L ENPEP

5.63e-055512gudmap_kidney_adult_RenMedVasc_Tie2_k3_100
CoexpressionAtlaskidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_200

SAMD9L GVINP1 IFIT2 ENPEP IFIT3

5.72e-05172515gudmap_kidney_adult_RenMedVasc_Tie2_200
CoexpressionAtlaskidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_500

SAMD9L GVINP1 NEK7 IFIT2 ENPEP IFIT3 MAP3K5

8.01e-05438517gudmap_kidney_adult_RenCorpuscGlomer_500
CoexpressionAtlasalpha beta T cells, T.4SP24-.Th, 4+ 8- TCRhi 24-/lo, Thymus, avg-3

CELSR1 IKBKE OAS2 IFIT2 IFIT3 CCND2

2.32e-04365516GSM399370_500
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000

CHODL ATRX PKHD1 COLGALT1 ENPEP

2.42e-04234515gudmap_developingGonad_e18.5_epididymis_1000_k5
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SAMD9L ATG3 OAS2 IFIT2 IFIT3 MAP3K5

4.17e-0817051607b561cd9c528bc8444c9385e1de621eee7b697e
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SAMD9L ZEB1 ZNF521 OAS2 IFIT2 IFIT3

7.33e-08187516f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCellBAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters

ATP6V1B2 SAMD9L ADAM19 OAS2 IFIT2 IFIT3

1.06e-071995169f5750212b887f92761ade33fc6e108cd5275297
ToppCellCOVID-19_Moderate|World / disease group, cell group and cell class

SAMD9L ZEB1 ATRX OAS2 IFIT3 CCND2

1.06e-07199516952fac67588ad5676f5939e3c7f8bac803c27064
ToppCellIIH-CD4-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster

IFT140 SAMD9L OAS2 IFIT2 IFIT3

7.48e-07148515ec626a44cea83f2a0e5c27fc8182f96446d297ac
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L OAS2 IFIT2 IFIT3 RXRG

1.13e-06161515b14a83ad07a7acb07c766aa862b527698976b6fc
ToppCellfacs-Brain_Myeloid-Cerebellum_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L OAS2 IFIT2 IFIT3 RXRG

1.13e-061615155c762609531a7c5505aa5637abf8e0311568d7fd
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L OAS2 IFIT2 IFIT3 RXRG

1.13e-06161515c5d9d47dcedfbb1ac77f4afaf860ae4d9f26fd3f
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L OAS2 IFIT2 IFIT3 RXRG

1.13e-0616151526c0d876339bfd34d9a43af5b9fb08f50526f2c9
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L OAS2 IFIT2 IFIT3 RXRG

1.32e-061665154ab1959c526c2fd83077fc03e4de207f34841a19
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SAMD9L ZNF257 MCM2 IFIT2 IFIT3

1.36e-06167515a54b8e03987a7b067173121902e1811a3d003692
ToppCellBAL-Control-cDC_1|Control / Compartment, Disease Groups and Clusters

SAMD9L ATG3 OAS2 IFIT2 IFIT3

1.81e-06177515aa021f6d62e9d740c5ea499faaf875de835a2865
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L GVINP1 ATRX IFIT2 IFIT3

1.86e-0617851501dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

SAMD9L OAS2 IFIT2 IFIT3 ZNF292

2.13e-061835158f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellB_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

SAMD9L ADAM19 OAS2 IFIT2 IFIT3

2.13e-06183515dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCellControl-CD8+_T_activated|Control / Disease group and Cell class

ATP6V1B2 SAMD9L OAS2 IFIT2 IFIT3

2.18e-06184515b86cc48b744b3206880ec1373fe6068e14bf9680
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SAMD9L PKHD1 OAS2 IFIT2 IFIT3

2.24e-06185515f30fb9d75cdb757b206312992aaf7485bc900f96
ToppCellMacrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

SAMD9L RARA COLGALT1 IFIT2 IFIT3

2.49e-06189515c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCellLPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZEB1 ZNF521 OAS2 IFIT2 IFIT3

2.69e-06192515c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCellPBMC-Mild|PBMC / Compartment, Disease Groups and Clusters

SAMD9L SIPA1L1 OAS2 IFIT2 IFIT3

2.83e-06194515d1366b169d14011194e61d16b6b0953349febc78
ToppCellMild-CD4+_T_activated|World / Disease group and Cell class

SAMD9L RARA OAS2 IFIT2 IFIT3

2.98e-06196515417b4fc2e4388f34c410576131b02936f93e46b6
ToppCellControl-Myeloid-TRAM3|Control / Disease group,lineage and cell class （2021.01.30）

SAMD9L ATG3 OAS2 IFIT2 IFIT3

3.05e-06197515733ff40039d67e561c2ded7c9bd0b4353101741e
ToppCellCV-Moderate-1|CV / Virus stimulation, Condition and Cluster

SAMD9L ADAM19 OAS2 IFIT2 IFIT3

3.05e-06197515e3d00d850b4d191f9592ef993c0eaadfe5710b5f
ToppCellBAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SAMD9L ATG3 OAS2 IFIT2 IFIT3

3.05e-061975150f1c4a328968b32874e6ebb0803e665adcbbc450
ToppCellsevere-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SAMD9L RARA OAS2 IFIT2 IFIT3

3.05e-06197515c8a90d82170cf20e14aebecddcf7cc0ca56cda87
ToppCellBAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SAMD9L ATG3 OAS2 IFIT2 IFIT3

3.05e-06197515aafe0cd697b0b7f0756596148e0906443fdf8ef7
ToppCellBAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SAMD9L ATG3 OAS2 IFIT2 IFIT3

3.05e-06197515e131634bc67e0bd31a938a8e8df8dc752e1d0f47
ToppCellBAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

SAMD9L ATG3 OAS2 IFIT2 IFIT3

3.05e-061975154416efdbd9c4ac3356a5dff2d535c2d7383376a9
ToppCellsevere-Myeloid-Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SAMD9L RARA OAS2 IFIT2 IFIT3

3.13e-06198515636878836678a0715550fa09f2e3dac11c4d73fe
ToppCellControl-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class

SAMD9L OAS2 IFIT2 IFIT3 CCND2

3.13e-06198515ee71543559836fd59adc0da877b2ca538cba60cb
ToppCellPBMC-Severe|PBMC / Compartment, Disease Groups and Clusters

SAMD9L ADAM19 OAS2 IFIT2 IFIT3

3.21e-06199515b428d95d3c90b28f658f652a768588a8ced4abd9
ToppCellBAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters

ATP6V1B2 SAMD9L OAS2 IFIT2 IFIT3

3.21e-06199515c55181bdec8952b54198f0d4c9c5c84265b16572
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class

SAMD9L OAS2 USP9Y IFIT3 CCND2

3.28e-062005152281debd86e5d92e8fe0397aec9ef670800f7471
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SAMD9L ATRX OAS2 IFIT3 ZNF292

3.28e-0620051512f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class

SAMD9L OAS2 USP9Y IFIT3 CCND2

3.28e-06200515d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ADAM19 ZNF257 PKHD1 COLGALT1

1.59e-05132514a1fda8c5287168c4f159203ed27cadfb4ce1b131
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NEK7 IFIT2 IFIT3 RXRG

1.64e-05133514fc319644868078ea0f88a71d55f5e858c6848b50
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

RARB IFIT2 IFIT3 RXRG

1.69e-05134514657ad905b40ec3f82acdef824431b8276d291ef7
ToppCellfacs-Skin-Anagen-3m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L OAS2 IFIT2 IFIT3

2.18e-05143514250f60f06f262f00acd14b09b3ef90dbb9759336
ToppCellfacs-Skin-Anagen-3m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L OAS2 IFIT2 IFIT3

2.18e-051435140c7c0d7ca040e87412295672cd1f065c0e941391
ToppCellfacs-Skin-Anagen-3m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L OAS2 IFIT2 IFIT3

2.18e-0514351427f4896276342758651fe7a80d7408ac5e1be9c0
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

RARB IFIT2 IFIT3 RXRG

2.69e-05151514090b067873740c282865e2d02cf47d5cb3dd7607
ToppCellMS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster

SAMD9L OAS2 IFIT2 IFIT3

2.77e-05152514b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell368C-Myeloid-Macrophage-FABP4+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells)

SAMD9L RARA COLGALT1 IFIT3

2.84e-05153514e0fbbfd4d13031412e0b985322c8b99c56eb7af5
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NEK7 IFIT2 IFIT3 RXRG

2.99e-0515551479264ff283e36a059040a5aa9fe7337be694cb52
ToppCellfacs-Skin-nan-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PKHD1 USP9Y ENPEP RXRG

2.99e-05155514fa2776d258e0420b2895de1008e292ad7725dac0
ToppCellPBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters

SAMD9L OAS2 IFIT2 IFIT3

3.06e-051565149b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc
ToppCellfacs-Brain_Myeloid-Cerebellum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L RARA OAS2 CCND2

3.22e-05158514f41ee21e5888359d817be1e3a902c132cb68e350
ToppCellfacs-Brain_Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L RARA OAS2 CCND2

3.22e-05158514d689feb7f612aef170da76fcf14abf2dd589082b
ToppCellfacs-Brain_Myeloid-Cerebellum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L RARA OAS2 CCND2

3.22e-05158514829ff3df46f173f2ff1c435e9bce35425e603b42
ToppCellFLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster

SAMD9L OAS2 IFIT2 IFIT3

3.30e-0515951497c8e16a7ac10ebba96daee97f9fb1d4a404f23b
ToppCellFLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster

SAMD9L OAS2 IFIT2 IFIT3

3.30e-05159514fe2a9f79b058e89214256e736f6e266830cdfa28
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SAMD9L OAS2 IFIT2 IFIT3

3.63e-05163514d005115aa1e1458b51de7eb719794617a4168608
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RARB CHODL FSHR ZNF521

4.18e-05169514319cba07263bf41fcbcbfecd117f91b729394241
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RARB CHODL FSHR ZNF521

4.58e-051735149a2d42f8d9cb834856522661d524abb91c4637c5
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SAMD9L OAS2 IFIT2 IFIT3

4.79e-0517551497616bb5c127284aa9e67bc336dfcf29e137164b
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SAMD9L OAS2 IFIT3 CCND2

5.01e-05177514d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L GVINP1 IFIT2 IFIT3

5.01e-05177514ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SAMD9L OAS2 IFIT3 CCND2

5.01e-05177514f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L GVINP1 IFIT2 IFIT3

5.01e-05177514f471f7747d6e8db7546899019af9508f48a14f89
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

SAMD9L OAS2 IFIT3 CCND2

5.01e-05177514936ab2b180a052387124f68d0c7f41c0b164e748
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L GVINP1 IFIT2 IFIT3

5.01e-05177514cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SAMD9L OAS2 IFIT3 CCND2

5.01e-05177514d5aeda113afaa2425874394610344570c9078478
ToppCellSevere-CD4+_T_activated|Severe / Disease group and Cell class

SAMD9L OAS2 IFIT2 IFIT3

5.01e-05177514a08f170f1143fcdd7d0842a54d9b807a4548f8b7
ToppCellCOVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class

SAMD9L OAS2 IFIT3 CCND2

5.01e-051775146978a22fef40c8b455342373abe7593f5ede0fa4
ToppCellSevere-CD4+_T_activated|World / Disease group and Cell class

SAMD9L OAS2 IFIT2 IFIT3

5.12e-05178514ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCellT_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

SAMD9L OAS2 IFIT2 IFIT3

5.23e-05179514af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SAMD9L OAS2 IFIT3 CCND2

5.58e-05182514b427e43ee523a3ea9eca3207f3d82042f10f022a
ToppCellNS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SAMD9L ATG3 IFIT2 IFIT3

5.58e-05182514e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

SAMD9L OAS2 IFIT3 CCND2

5.58e-051825141aea96ee211f7b9caef7fd385233f51be6021a73
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SAMD9L OAS2 IFIT3 CCND2

5.58e-05182514c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SAMD9L OAS2 IFIT3 CCND2

5.58e-051825144cb182ef39be2044a6ad7266f332d4177591e550
ToppCellMild-CD4+_T|World / Disease group and Cell class

RARA OAS2 IFIT2 IFIT3

5.70e-05183514c4ac8893d38a3da4e19fe2ef1756bd69c89e975c
ToppCellmoderate-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SAMD9L OAS2 IFIT2 IFIT3

5.70e-051835144ba879552e2101a341f3224826d364ac64c72260
ToppCellCOVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations)

ADAM19 CHODL FNDC3A CCND2

5.70e-05183514130c109f63a5e3c8f83cb96e32f4addf513b6415
ToppCellCOVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations)

ADAM19 CHODL FNDC3A CCND2

5.70e-051835142c016bb59f131a0e821853b085289a3583f0a729
ToppCellCOVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class

SAMD9L OAS2 IFIT3 CCND2

5.70e-051835147717fce227b4e02ed41baad8ae7dd2e22bd7c13e
ToppCellCOVID-19_Mild-CD8+_T_activated|COVID-19_Mild / Disease condition and Cell class

SAMD9L OAS2 IFIT2 IFIT3

5.70e-05183514ac1ca5d613fa9888ccc63cb0bdce95aefd02cdd7
ToppCellPBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters

ATP6V1B2 ADAM19 OAS2 IFIT3

5.82e-051845142e0c9a2c40c892a2d435eafb31f1f838de9baf15
ToppCellCOPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class

ZEB1 MAP3K5 ZNF292 CCND2

5.95e-05185514846403edd4c8f646201d519055198fc38b7ffff9
ToppCellCOVID-19_Severe-CD8+_T_activated|COVID-19_Severe / Disease condition and Cell class

SAMD9L OAS2 IFIT2 IFIT3

6.07e-05186514fc087b79240fe7ada5810d4f4b3c7287eab598ff
ToppCellcritical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SAMD9L OAS2 IFIT2 IFIT3

6.20e-0518751472e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad
ToppCellsystemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

RARA ATG3 IFIT2 IFIT3

6.33e-051885143e94d105ca96ceb5fdcca39a8050217913bc02da
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZEB1 ZNF521 IFIT2 IFIT3

6.33e-0518851473f6ec915934154f435a376cb274b058ff7c5f35
ToppCellT_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

SAMD9L OAS2 IFIT2 IFIT3

6.33e-051885146f8946d4710f6e32c937213f99b790b098b8819c
ToppCellcritical-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SAMD9L OAS2 IFIT2 IFIT3

6.33e-05188514023f6e34c2db8657d25e70a97b7b9d45166c13ad
ToppCellLPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF521 OAS2 IFIT2 IFIT3

6.33e-05188514789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCellILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ATRX MCM2 FNDC3A ZNF292

6.46e-05189514a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZEB1 ADAM19 ATRX CCND2

6.59e-05190514d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF521 OAS2 IFIT2 IFIT3

6.59e-05190514a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PKHD1 OAS2 IFIT2 IFIT3

6.59e-05190514e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PKHD1 OAS2 IFIT2 IFIT3

6.59e-051905146de15ec88426fbf52acb0a8371f82cf03b6a6237
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L ATRX PITPNA FNDC3A

6.73e-0519151460c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCellCalu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain

SAMD9L OAS2 IFIT2 IFIT3

6.73e-051915142da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L ATRX PITPNA FNDC3A

6.73e-0519151409db184cb90fe282a14474d7217068c58092c6f8
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PKHD1 OAS2 IFIT2 IFIT3

6.73e-0519151481f77bf497b8e0ae0affe7d5f4f00446547229f6
ToppCellMild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SAMD9L OAS2 IFIT2 IFIT3

6.73e-05191514382686d62f7b8576c44bb9726a4e10dc26fd348e
ToppCellLPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZEB1 ZNF521 IFIT2 IFIT3

6.73e-05191514a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD9L ATRX PITPNA FNDC3A

6.73e-05191514973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellfacs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CELSR1 PITPNA MCM2 CCND2

6.87e-05192514ec1fd2fb6e71f87189d66261909a84e2be63cacb
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

SAMD9L OAS2 IFIT2 IFIT3

1.19e-0550314GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_INTERFERON
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

SAMD9L OAS2 IFIT2 IFIT3

1.19e-0550314GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_INTERFERON
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

SAMD9L OAS2 IFIT2 IFIT3

1.19e-0550314GAVISH_3CA_METAPROGRAM_B_CELLS_INTERFERON
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

SAMD9L OAS2 IFIT2 IFIT3

1.19e-0550314GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

SAMD9L OAS2 IFIT2 IFIT3

1.19e-0550314GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_INTERFERON
ComputationalNeighborhood of MSH3

ATRX IKBKE SURF2 PITPNA FSHR RXRG

5.75e-05243316MORF_MSH3
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

ADAM19 ATRX ZNF292

3.88e-0450313GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1
DrugAlitretinoin

RARA RARB RXRG

2.11e-076513DB00523
DrugAdapalene

RARA RARB RXRG

2.11e-076513DB00210
DrugEtretinate

RARA RARB RXRG

2.11e-076513DB00926
DrugAminophylline [317-34-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A

RARA ATG3 IKBKE SIPA1L1 OAS2 FNDC3A ENPEP

3.03e-072005175395_DN
DrugAcitretin

RARA RARB RXRG

3.68e-077513DB00459
DrugHX 600

RARA RARB RXRG

5.88e-078513ctd:C104181
DrugTTNN

RARA RARB RXRG

5.88e-078513CID000135754
Drugretinyl methyl ether

RARA RARB RXRG

8.81e-079513CID006436634
DrugHX 630

RARA RARB RXRG

1.26e-0610513ctd:C422175
DrugUVI 3003

RARA RARB RXRG

1.73e-0611513ctd:C525131
DrugCd2665

RARA RARB RXRG

2.98e-0613513CID000216241
DrugAC1L1DMQ

RARA RARB RXRG

3.79e-0614513CID000002418
DrugBIX 01294

OAS2 IFIT2 IFIT3

3.79e-0614513ctd:C518299
DrugIopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A

ADAM19 RARA IKBKE CAMTA2 VPS53 ENPEP

4.64e-061945165448_DN
DrugRo 8-8717

RARA RARB

4.92e-062512CID006438148
DrugTamibarotene

RARA RARB

4.92e-062512DB04942
DrugPiromidic acid [19562-30-2]; Down 200; 13.8uM; PC3; HT_HG-U133A

RARA IKBKE OAS2 FNDC3A ZNF721 ZMYM6

5.06e-061975164575_DN
DrugPerphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A

ZEB1 ADAM19 RARA RARB IKBKE SIPA1L1

5.37e-061995165698_DN
DrugHX600

RARA RARB RXRG

8.44e-0618513CID000128016
Drug3,4-didehydroretinoic acid

RARA RARB RXRG

8.44e-0618513CID000447276
DrugUNC 0638

OAS2 IFIT2 IFIT3

8.44e-0618513ctd:C561310
DrugTriiodothyronine

ADAM19 RARA RARB PITPNA FSHR MCM2 RXRG CCND2

1.01e-05477518ctd:D014284
Drugadapalene

RARA RARB RXRG

1.58e-0522513CID000060164
DrugRo 15-0778

RARA RARB RXRG

1.82e-0523513CID006436116
DrugAC1L32JQ

RARA RARB RXRG

1.82e-0523513CID000133319
Drug9-cis-acitretin

RARA RARB IFIT3 RXRG

1.94e-0571514CID000041317
DrugSRI 5898-21

RARA RARB

2.94e-054512CID006439757
DrugTazarotene

RARA RARB

2.94e-054512DB00799
DrugAC1L2X6Z

RARA RARB RXRG

2.98e-0527513CID000130325
DrugRo 41-5253

RARA RARB OAS2

4.12e-0530513ctd:C084904
DrugAGN 193109

RARA RARB RXRG

4.55e-0531513CID000177238
DrugCd2366

RARA RARB

4.90e-055512CID006443796
DrugCD367

RARA RARB RXRG

5.51e-0533513CID000119342
Drugdiisobutyl phthalate

FSHR RXRG CCND2

5.51e-0533513ctd:C025605
DrugHexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A

IFT140 SIPA1L1 DNAH17 IFIT2 IFIT3

5.82e-051855152457_UP
Drugeq N

RARA RARB OAS2 RXRG

5.87e-0594514CID000002126
DrugEconazole nitrate [24169-02-6]; Up 200; 9uM; PC3; HT_HG-U133A

RARA OAS2 ZNF721 IFIT2 IFIT3

6.61e-051905157305_UP
DrugCefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A

IFT140 DNAH17 ZNF407 VPS53 ENPEP

7.11e-051935154067_DN
Drugchlorpromazine hydrochloride; Up 200; 10uM; MCF7; HG-U133A

SURF2 DNAH17 OAS2 FNDC3A IFIT2

7.47e-05195515419_UP
DrugChlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; PC3; HT_HG-U133A

ZNF407 IFIT2 VPS53 IFIT3 CCND2

7.47e-051955156692_UP
DrugMethoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A

CELSR1 ADAM19 RARA SIPA1L1 ENPEP

7.47e-051955155007_UP
DrugEthotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A

ZEB1 RARA ATRX DNAH17 OAS2

7.65e-051965154366_DN
DrugRo 41-5253

RARA RARB RXRG

7.80e-0537513CID005312120
Drugpioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A

RARA ATRX FNDC3A VPS53 ZMYM6

7.84e-051975155925_UP
DrugTropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A

SIPA1L1 ZNF407 VPS53 ENPEP ZMYM6

7.84e-051975154744_DN
DrugKawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A

IFT140 ZEB1 ADAM19 IKBKE ENPEP

7.84e-051975154693_DN
Drugnovobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A

RARB OAS2 IFIT2 IFIT3 RXRG

7.84e-05197515576_UP
DrugTobramycin [32986-56-4]; Down 200; 8.6uM; PC3; HT_HG-U133A

IFT140 ZNF407 FNDC3A ENPEP ZMYM6

8.03e-051985154081_DN
DrugTroleandomycin [2751-09-9]; Down 200; 5uM; PC3; HG-U133A

IKBKE ZDHHC6 SURF2 PITPNA IFIT3

8.03e-051985151885_DN
DrugBemegride [64-65-3]; Down 200; 25.8uM; HL60; HT_HG-U133A

IFT140 ZEB1 ADAM19 SIPA1L1 ZNF407

8.03e-051985153051_DN
DrugLY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

IFT140 RARA ATG3 VPS53 MAP3K5

8.03e-05198515996_UP
DrugTheobromine [83-67-0]; Down 200; 22.2uM; HL60; HT_HG-U133A

IFT140 ATG3 ZNF407 IFIT2 ZMYM6

8.03e-051985152995_DN
DrugMephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A

ZEB1 ADAM19 RARA IKBKE ENPEP

8.03e-051985154698_DN
Drugtazarotene

RARA RARB RXRG

9.87e-0540513CID000005381
Drugvitamin D3 analog

RARA RARB RXRG

1.06e-0441513CID006438384
Drugacyclic retinoid

RARB RXRG CCND2

1.06e-0441513CID006437836
Drugcarbonyl sulfide

RARA FSHR USP9Y MAP3K5

1.33e-04116514CID000010039
Drug2-naphthoic acid

RARA RARB

1.37e-048512CID000007123
Drug4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid

RARA RARB

1.37e-048512ctd:C064545
DrugAdapalene

RARA RARB

1.37e-048512ctd:D000068816
DrugAC1O5JP6

RARA RXRG

1.37e-048512CID006435379
Drug4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid

RARA RARB

1.37e-048512ctd:C121616
DrugEtretinate-d3

RARA RARB RXRG

1.41e-0445513CID000003312
DrugS-(+)-Methoprene

RARA FNDC3A RXRG

1.50e-0446513CID000038532
DrugBetamethasone-d5

IVD UBA52 RARA RARB TESMIN IKBKE FSHR FNDC3A ACVR1 RXRG CCND2

1.51e-0413405111CID000003003
Drugdiethyl phthalate

FSHR RXRG CCND2

1.71e-0448513ctd:C007379
DrugRe80

RARA RXRG

1.75e-049512CID006440834
DrugAC1L1JB6

UBA52 RARB RXRG CCND2

2.12e-04131514CID000004961
Drugcadmium sulfide

UBA52 ATG3 MAP3K5

2.17e-0452513ctd:C034939
DrugCEPC

RARA RARB

2.19e-0410512CID000011483
Drug4-hydroxyretinoic acid

RARA RARB

3.20e-0412512ctd:C019429
Drugtamibarotene

RARA RARB ATRX OAS2 CAMTA2 IFIT3 RXRG

3.47e-04596517ctd:C061133
Drughexamethylene bisacetamide

RARA MCM2 IFIT3

3.48e-0461513ctd:C014026
Drugtazarotenic acid

RARB RXRG

3.78e-0413512CID000147525
Drugpoly r(A-U

IKBKE OAS2

3.78e-0413512CID000032741
DrugRo 13-6298

RARA RARB

3.78e-0413512CID006437076
DrugAzaguanine-8 [134-58-7]; Up 200; 26.2uM; HL60; HT_HG-U133A

SIPA1L1 DNAH17 FNDC3A CAMTA2

4.43e-041595141833_UP
Drugretinamide

RARA RARB RXRG

5.00e-0469513CID005370221
DrugAC1L1JIR

RARA RARB RXRG

5.66e-0472513CID000005058
DrugTAC 101

RARA RARB

5.79e-0416512ctd:C112689
DrugGW0072

RARB FSHR

6.55e-0417512CID000449532
Drugprotoporphyrin IX dimethyl ester

RARA RARB

6.55e-0417512CID000194637
Drugthioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A

IFT140 SIPA1L1 IFIT2 IFIT3

6.63e-041775142690_UP
DrugMefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; PC3; HT_HG-U133A

OAS2 ACVR1 IFIT2 IFIT3

6.78e-041785142048_UP
DrugGriseofulvin

RARA RARB RXRG

6.89e-0477513ctd:D006118
DrugAC1L1KPQ

RARA RARB RXRG

7.16e-0478513CID000005602
DrugSR11237

RARA RARB

7.36e-0418512CID000127019
Drug4-(1H-imidazol-1-yl)retinoic acid

RARA RARB

7.36e-0418512ctd:C496751
Drugretinol palmitate

RARA RXRG

7.36e-0418512ctd:C014794
DrugAlexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; HL60; HT_HG-U133A

TESMIN ACVR1 IFIT2 IFIT3

7.36e-041825142576_UP
DrugIsoetharine mesylate salt [7279-75-6]; Up 200; 12uM; HL60; HT_HG-U133A

RARA SIPA1L1 DNAH17 ZMYM6

7.67e-041845142711_UP
DrugA-74702

RARA RARB RXRG

7.70e-0480513CID000452307
DrugSuloctidil [54063-56-8]; Up 200; 11.8uM; PC3; HT_HG-U133A

ZNF407 IFIT2 ENPEP IFIT3

7.99e-041865146675_UP
DrugWithaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A

RARA IKBKE SIPA1L1 MAP3K5

7.99e-041865143902_DN
DrugHhAntag691

ZEB1 CCND2

8.21e-0419512ctd:C538724
DrugA-FN

FSHR FNDC3A

8.21e-0419512CID005287635
DrugDehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A

RARA OAS2 IFIT2 IFIT3

8.31e-041885145019_UP
DrugPrednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ZEB1 OAS2 VPS53 ZMYM6

8.48e-041895144400_DN
DrugOxybutynin chloride [1508-65-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A

IKBKE OAS2 IFIT2 IFIT3

8.48e-041895146770_UP
Drugrottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA

ATRX FNDC3A CAMTA2 MAP3K5

8.64e-04190514914_UP
DiseaseNeuralgia-Neuritis, Sciatic Nerve

RARA RARB

1.62e-054492C0751924
DiseaseSciatic Nerve Palsy

RARA RARB

1.62e-054492C0751925
DiseaseLesion of Sciatic Nerve

RARA RARB

1.62e-054492C0154748
DiseaseSciatic Neuritis

RARA RARB

1.62e-054492C0242013
DiseaseSciatic Neuropathy

RARA RARB

1.62e-054492C0149940
DiseaseInfluenza

OAS2 IFIT2 IFIT3

8.98e-0552493C0021400
Diseasegranulosa cell tumor (is_marker_for)

FSHR CCND2

1.47e-0411492DOID:2999 (is_marker_for)
Diseaselung small cell carcinoma (is_implicated_in)

RARB ATRX

9.93e-0428492DOID:5409 (is_implicated_in)
Diseaseeosinophil percentage of leukocytes

CELSR1 ADAM19 RARB IKBKE ACVR1 ZNF292

1.42e-03746496EFO_0007991

Protein segments in the cluster

PeptideGeneStartEntry
QQCVQYFEMCKTRKA

TBC1D32

386

Q96NH3
VLMLMYYCCRQNNKL

ADAM19

716

Q9H013
PKGKNYYKNQQMCCV

GVINP1

1031

Q7Z2Y8
YQKGCFQVYEQGKMT

ACVR1

66

Q04771
KLKVQGMECLYGCYV

CAMTA2

106

O94983
TNGQCQCKENYYKLL

CELSR1

1981

Q9NYQ6
IDNYQVKCINGKMCY

C3orf70

131

A6NLC5
TKNVPCYKRCKQMEY

ATG3

76

Q9NT62
QYCRLQKCFEVGMSK

RARA

141

P10276
QYCRLQKCFEVGMSK

RARB

141

P10826
LVNQKDCPYMCAYKL

PITPNA

181

Q00169
QLSMVKYNCNKCNFV

MCM2

321

P49736
CSYFKCVQKDIQPYM

CCND2

41

P30279
QQIQCCLDKMNFIYK

IKBKE

541

Q14164
YYLMVKENLCVVCGK

EXD2

411

Q9NVH0
MNLYSLCKKIEQCDY

NEK7

241

Q8TDX7
GCQMYLEKYQFKNAK

ENPEP

501

Q07075
LMACRQYVYNVAKAC

IVD

336

P26440
KCQEKLCIYWMVNYN

OAS2

256

P29728
AQKYNCDKMICRKCY

UBA52

86

P62987
SLQVLICKNCFKYYM

ATRX

191

P46100
KELYQTYDFCCVNMK

DNAH17

381

Q9UFH2
EFCQCYMGSQKQFKI

FNDC3A

416

Q9Y2H6
IGCCYKAKVRQMQNT

IFIT3

281

O14879
QIGCCYRAKVFQVMN

IFIT2

286

P09913
LSKCGCYEMQAQIYR

FSHR

641

P23945
RVYVYCINNKMCCVK

DEFB123

41

Q8N688
FSCKQAEVQMYVCNK

COLGALT1

271

Q8NBJ5
FEKGENMNCVCYCKV

IFT140

321

Q96RY7
GCLKNYCECYEAQIM

TESMIN

376

Q9Y4I5
KEIICQKNTMCTGNY

MAP3K5

196

Q99683
QLYACYAIGKDVQAM

ATP6V1B2

421

P21281
CNDKYFYIQMQICKD

SAMD9L

316

Q8IVG5
GLNYQQKVGIMYCKA

SIPA1L1

606

O43166
KAQNQKKMYYNCSCI

SLCO6A1

536

Q86UG4
EQKCTYQFLMQGFIC

PKHD1

3391

P08F94
YQRALCKYEECQKQG

SURF2

106

Q15527
NDDRCNMKHNYICKY

CHODL

166

Q9H9P2
ISQDTMYLQYCKVCQ

ZDHHC6

91

Q9H6R6
YKCNECGTIFRQKQY

ZNF260

276

Q3ZCT1
EKKTYQCIKCQMVFY

ZNF521

1191

Q96K83
CKSMNVCKVQKGVYN

ZNF721

41

Q8TF20
ICIQMKCKAGFNSYA

ZNF292

751

O60281
CQYCRYQKCLVMGMK

RXRG

191

P48443
YQKRAYQCIKCMVAL

USP9Y

2381

O00507
VYYKKCMVQCSQLST

VPS53

476

Q5VIR6
NGMYACDLCDKIFQK

ZEB1

901

P37275
VLFYQMAKCDGCKRQ

ZMYM6

551

O95789
LRCYCQAMQVYKGKG

TRAPPC8

581

Q9Y2L5
REENQGNVCKYCGKM

ZNF407

1531

Q9C0G0
CLITTQSKMYQCDKY

ZNF257

136

Q9Y2Q1